Facense

Company Overview

Snapshot

Founded in May 2015 by Gil Thieberger, Ori Tzvieli, Tal Thieberger-Navon, and Arie Tzvieli, Facense operates with 1–10 employees. The company has secured funding across two rounds and holds an extensive IP portfolio with 37 granted US patents.

Business overview

Facense develops smartglasses equipped with small sensors that continuously and unobtrusively measure vital signs and emotional responses. This technology aims to detect and predict various medical conditions, including hypertension, stroke, congestive heart failure, asthma, COPD, migraines, and early COVID-19 symptoms. Serving the Health Tech & Life Sciences sector, Facense enhances telehealth applications and provides medical solutions through continuous physiological monitoring, targeting markets in the United States, Southeast Asia, and Europe.

Company Intelligence Q&A

What is Facense's primary product?

Facense's primary product is smartglasses equipped with sensors that continuously monitor the wearer's vital signs and emotional responses to detect and predict various medical conditions.

When was Facense founded?

Facense was founded in May 2015.

Who are the founders of Facense?

Facense was founded by Gil Thieberger, Ori Tzvieli, Tal Thieberger-Navon, and Arie Tzvieli.

What is the status of Facense's operations?

Facense is currently non-active, having ceased to operate in June 2026.

What is Facense's intellectual property status?

Facense holds an extensive IP portfolio, including 37 granted US patents and dozens of patent applications globally, related to smartglasses with sensors for wellness, telehealth, safety, and industrial applications.